Iterum Therapeutics plc (ITRM:NASDAQ) closed at $0.030 on March 31, 2026, unchanged on the day. The stock trades 97.9% below its 52-week high of $1.42 and 10.7% above its 52-week low of $0.027. Iterum Therapeutics plc is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 14, 2025, ITRM closed higher on 47 days (19%). Its best day was April 13, 2026 (+115.83%) and its worst was March 27, 2026 (-79.77%). The stock moved 10% or more in a single session 19 times. It opened at least 5% above the previous day's high 4 times.
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Find more stocks like ITRM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.